$162.78▼-3.06 (-1.84%)
Pre-Market:$162.00-0.78 (-0.48%)· 8:45 PM ET
Neurocrine Biosciences, Inc. (NBIX)
Operating Expenses
$2.74B
TTM · Period ending: · USD

NBIX Operating Expenses
Latest reported$2.74Bperiod ending
Latest reported$2.74Bperiod ending
NBIX Operating Expenses ($17.30M → $2.74B)
Annual operating expenses
High-resolution chart · PNG
What is operating expenses?
Expenses from normal business operations (SG&A, R&D, etc.).
NBIX operating expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 2,189,300,000 | |
| 1,750,800,000 | |
| 1,596,500,000 | |
| 1,216,500,000 | |
| 1,016,700,000 | |
| 872,800,000 | |
| 708,400,000 | |
| 409,500,000 | |
| 291,733,000 | |
| 162,372,000 | |
| 113,971,000 | |
| 64,411,000 | |
| 52,597,000 | |
| 51,692,000 | |
| 43,491,000 | |
| 47,223,000 | |
| 56,623,000 | |
| 91,273,000 | |
| 213,466,000 | |
| 152,551,000 | |
| 148,961,000 | |
| 137,510,000 | |
| 197,865,000 | |
| 121,660,000 | |
| 85,124,000 | |
| 52,387,000 | |
| 38,800,000 | |
| 30,100,000 | |
| 26,900,000 | |
| 17,300,000 |
Explore More
NBIX Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance